Objective: Chronic beta-adrenoceptor antagonist (b-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response. However, the underlying electrophysiological mechanisms are presently unclear. We aimed to investigate electrophysiological changes in human atrial cells associated with chronic treatment with b-blockers and other cardiovascularacting drugs. Methods: Myocytes were isolated enzymatically from the right atrial appendage of 40 consenting patients who were in sinus 
AF. Metoprolol was more effective than placebo [3] , and Nitrate 25 63 bisoprolol was as effective as sotalol [4] , in preventing CCB 18 45 relapse into AF after cardioversion. Additionally, atenolol ACE inhibitor 14 35 reduced the incidence and duration of paroxysmal AF [5] . tential duration (APD) in atria and ventricles [6] . However, repolarisation are presently unclear, with conflicting reSevere dysfunction 4 10 ports in the ventricle (lengthening [7] and shortening [8] )
Disease Angina 33 82
and no available data, to our knowledge, in the atrium. Hyperlipidaemia 26 65 AF is maintained by intra-atrial reentry, facilitated by a Hypertension 18 45 Previous MI 16 40 shortened atrial effective refractory period (ERP). Atrial Diabetes 4 10 electrophysiological remodelling due to AF contributes to
Values are numbers of patients (n and % of total, respectively) with stabilisation of the arrhythmia, and is associated with selected clinical characteristics, except for age (mean6S.E.). CCB5
shortening of the APD and ERP, as confirmed recently in calcium channel blocker; CABG5coronary artery bypass graft surgery;
our laboratory in human atrial myocytes [9] . It is conceiv- chronic use, a prolongation of the atrial cell APD and ERP. We wished to test this hypothesis, examine potential ionic mechanisms involved, and assess, for comparison, electrothe whole cell patch clamp technique, with an Axopatchphysiological changes associated with chronic use of other 1D amplifier (Axon Instruments). Cells were superfused at drugs acting on the cardiovascular system. 37 8C with a physiological salt solution containing (mM): The objective, therefore, was to investigate changes in NaCl (1.0), EGTA (0.15), Na ATP (4.0), Na GTP (0.4) and 2 2 HEPES (5.0). Series resistance and capacitative transients were compensated electronically prior to recording. Action 2 . Methods potentials were stimulated using 5-ms duration current pulses of 1.23 threshold strength, after current clamping 2 .1. Cell isolation the resting potential to 275 mV and keeping the holding current constant thereafter. The ERP was measured using a Right atrial appendage tissue was obtained from 40 standard S -S stimulation protocol, with an eight-pulse 1 2 patients undergoing corrective cardiac surgery (Table 1) . conditioning train (75 beats / min), and S and S pulses of Procedures approved by the institutional research ethics equal magnitude. The ERP was defined as the longest committee were followed, and each patient's informed S -S interval failing to elicit an S action potential of 1 2 2 consent was obtained. The investigation conforms with the amplitude .80% of the preceding S action potential. The 1 principles outlined in the Declaration of Helsinki [10] . APD was calculated as the interval between the action Atrial cells were isolated enzymatically with protease potential upstroke and repolarisation to the level of both 50 (Type XXIV, Sigma, 4 U / ml) and collagenase (Type 1, and 90% (APD and APD , respectively). The voltage 50 90
Worthington, 400 U / ml) using the method described clamp was used to record the cells' input resistance (R ),
previously [9] . the L-type Ca current (I ), the transient outward K cell's capacity, prior to the statistical analyses and graphtered included lisinopril (50%), captopril (21%), ramipril ing of mean data. Action potentials and ion currents were (21%) and enalapril (7%). Of the 14 patients on ACE stimulated, recorded and measured using 'WinWCP' softinhibitors, nine were on b-blockers, and six on CCBs. All ware, donated by J. Dempster, Strathclyde University.
cardio-active drugs had been administered for a minimum duration of 3 months.
.3. Data analysis and statistics

.2. Atrial cellular electrophysiological changes Details of each patient's clinical characteristics and drug
associated with chronic b-blockade treatments were obtained from the case notes. The cardiac rhythm and heart rate were assessed from the pre-operative patients not treated (top trace) and treated (bottom trace) cellular electrophysiological data were stored in a database with b-blockers. Chronic b-blockade was associated with a (Access, Microsoft) for subsequent analysis. Univariate lengthening of both the ERP and late repolarisation. electrophysiological measurements were compared beUnivariate analysis (simple regression) indicated that the tween pairs of various subgroups of patients using twomean APD and ERP were markedly and significantly 90 sided, two-sample unpaired Student's t-tests. Univariate longer in atrial cells from the patients receiving b-blockdata are expressed as cell means6standard error (S.E.).
ers, at 213611 ms (n521 cells, 15 patients) and 233611 Multiple linear regression [11] was then used to further ms (n516 cells, 11 patients), respectively, than in the investigate associations between patients' atrial elecnon-treated patients, at 176612 ms (n520 cells, 11 trophysiology and drug treatments or clinical characterispatients) and 184612 ms (n517 cells, 10 patients), tics. This provided an estimate of the difference in each respectively (Fig. 1B) . The univariate means within each electrophysiological measurement between the levels of patient group, and the probability values of differences the factor of interest, according to eight variables considbetween groups, were similar whether analysed at cell or ered to be of particular importance. These were the subject (patient) level. The changes in APD and ERP patients' drug treatments (b-blockers, calcium channel associated with chronic b-blockade were independent of blockers [CCBs] and angiotensin converting enzyme cell capacity or holding current, each of which were [ACE] inhibitors), age (for a 5-year increase), sex, heart similar in b-blocker-treated and non-treated patients, at rate (for a 5 beats / min increase), and the presence or ERP5effective refractory period; ACEI5ACE inhibitors; BB5b-blockers; HR5heart rate. The model is either 'Alone' (univariate), 'Drugs' (adjusting for all drugs) or 'All' (adjusting for all covariates). ERP estimate5estimated difference in mean ERP between highest (e.g. drug-treatment) and lowest (e.g. non-drug-treatment) level of variable, or male minus female. Values are subject (patient) means6standard error (S.E.M.); *P,0.05. preceding S action potential. In each case, the S response thus used to presence of previous myocardial infarction (Table 2) . Fig. 2D . Additionally, the R was higher in the atrial cells i respectively). Multiple regression analysis was used to from patients who underwent b-blockade than in untreated further investigate associations between patients' characpatients. This is illustrated in Fig. 2C (lower trace), by the teristics and electrophysiological changes. Table 2 prorelatively shallow slope of the ohmic portion of the vides an example of this analysis with respect to the atrial current-voltage relationship, and confirmed by univariate cell ERP. With ACE inhibitors and CCBs taken as covarianalysis (Fig. 2D) . The tangent to the ohmic portion ables ('Drugs'), the direction, magnitude and probability intersected zero current at 28163 mV (n515 cells), 1 value of the estimated difference in ERP between bcompared with the predicted K equilibrium potential of blocker-treated and non-treated patients were similar to 293 mV. This suggested that R was contributed to by the i 1 that found without adjusting for these covariables. When inward rectifier K current (I ). The density of atrial K1 all covariates were considered ('All'), the direction and I was not significantly different between patients who KSUS approximate magnitude of the difference were again were, and who were not, treated with b-blockers, at maintained, although the difference was no longer signifi-8.8161.74 pA / pF (n510 cells, seven patients) and also confirmed, whether the analysis incorporated all of the covariables, or the drugs alone. Since a reduction in atrial I has also been associated with congestive heart failure TO [12] , a sub-analysis of electrophysiological data was carried out in patients with and without significant (moderate or severe) left ventricular dysfunction (LVD). Eleven of the 25 b-blocker-treated patients (44%) had significant LVD, and four of the 15 non-b-blocker-treated patients (27%) had significant LVD. There was no significant difference in the proportion of patients with significant LVD between the two patient sub-groups (P50.28). Within both of these sub-groups, there was no significant difference between patients with and without LVD, in the atrial cell ERP, APD , I or R .
TO i
The potential contribution of the observed reduction in atrial I to associated changes in repolarisation and TO refractoriness was evaluated. Chronic b-blockade, in addition to prolonging the ERP (Fig. 1) , was associated with a significant slowing of the action potential maximum downstroke velocity, phase 1 V (Fig. 3A) . The I max TO blocker 4-aminopyridine (4-AP) produced a similar reduction in phase 1 V in cells from non-b-blocker-treated max patients ( Fig. 3B) , which was also accompanied by a significant prolongation in the ERP (Fig. 3C ).
.3. Lack of electrophysiological changes associated with calcium channel blockade or ACE inhibition
Chronic calcium channel blockade or ACE inhibition was not associated with any significant changes in the APD or ERP, as indicated by univariate mean data, shown in and I were supported by supported the lack of association between action potential TO i KSUS CaL multiple regression: with the 'Drugs' model, the estimated configuration, duration, the ERP, ion currents, and treatmagnitude of the reduction in I was 6.9 pA / pF (P5 ment with either CCBs or ACE inhibitors. Table 2 TO 0.03). In this analysis, the magnitude (but not the probprovides an example of this, indicating a lack of statistical ability value) of the increase in R was also maintained.
significance of any estimated difference in the ERP previous studies in animals [6, 16] . Thus, chronic meto- prolol treatment in rabbits lengthened the atrial APD, as well as the ventricular APD and ERP, and the QT interval c [6] , and the atrial effects were similar in magnitude to analysis, i.e. with drugs alone, or with consideration of all those reported here. In humans, only effects on the covariates.
ventricle have been studied, and chronic b-blockade prolonged both QT interval and monophasic action potentials [7, 17] especially during exercise [18] . However, an 4 . Discussion absence of change [19, 20] or even a shortening [8] , in QT interval or ERP have also been reported. Differences We report the novel finding that chronic b-blockade was between human atrial and ventricular responses may be associated with prolongation of action potentials and the expected, in view of, for example, the presence of a ERP in human atrial cells. These changes represent an sustained outward current in human atrium but not ventriadaptive response, a type of 'pharmacological remodelcle, and the relatively slow recovery kinetics of atrial I TO ling', whereby chronic blockade of the b-adrenoceptors [21] . Additionally, pharmacological remodelling by b-blockade in the rabbit was more rapid in the atrium than in [22] . Additionally, chronic b-stimulation increased the the ventricle [6] .
density of I in canine cultured ventricular myocytes [24] , TO The present study also addressed ionic changes underlyand an increase in both I and I occurred during TO K1 ing the effects of chronic b-blockade in human myocarsympathetic innervation of newborn rat hearts [25] . If one dium. We demonstrated a reduction in atrial I associated speculated that chronic b-blockade might produce the TO with chronic b-blockade, and provided evidence to suggest opposite effects, then a reduced I and I , as reported TO K1 that this may be a contributory ionic mechanism for the here, would be predicted by some [24, 25] , but not all [22] , lengthening of the action potential and ERP. Thus, the studies. velocity of phase 1, which is dependent on the magnitude Chronic calcium channel blockade or ACE inhibition of both I and I , was reduced by chronic b-blockade,
were not associated with adaptive changes in atrial ion TO CaL in the absence of a change in I . Furthermore, b-blockercurrents, action potentials or the ERP. Human atrial I CaL CaL induced changes in both phase 1 and ERP were largely was increased by acute ACE inhibition [26] , but no studies mimicked, in cells from non-b-blocker-treated patients, by could be found with chronic ACE inhibition. In a single the I blocker, 4-AP. However, it is recognised that 4-AP, report of effects of chronic CCB treatment on human atrial TO whilst the most specific I blocker currently available, electrophysiology [26] , a reduction in both the APD and [12] . In presently observed absence of associated atrial electrothe present study, however, the effects of chronic bphysiological changes, neither chronic calcium channel blockade to reduce I density were independent of cell blockade nor ACE inhibition has a proven efficacy in the The mechanisms of these electrophysiological changes A cknowledgements associated with chronic b-blockade are presently unclear. A chronically slowed heart rate by b-blockade might We thank the British Heart Foundation for financial lengthen the atrial APD and ERP recorded at constant support, and the Glasgow Royal Infirmary cardiac surgical stimulation rate, analogous to their shortening resulting operating teams for kindly providing atrial tissue. from chronic fast atrial rate [9] . However, the multiple regression analysis indicated that the observed prolongation of APD and ERP was independent of heart rate. An R eferences alternative mechanism is a direct regulation of expression of ion channels by chronic b-receptor modulation. Chronic 
